Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 461, 357-358 (17 September 2009) | doi:10.1038/461357a; Published online 16 September 2009
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Head-Preclinical
- Syngene International
- Bangalore, Karnataka 560099 India
Senior Faculty Positions
- Torrey Pines Institute for Molecular Studies
- Port St. Lucie, FL
Genomics: Hepatitis C virus gets personal
Shawn P. Iadonato1 & Michael G. Katze2
Abstract
Many people infected with the hepatitis C virus are not cured despite gruelling therapy. A human genetic variant that predicts successful treatment has been identified. So is personalized therapy now a possibility?
A staggering 170 million people are persistently infected with the hepatitis C virus (HCV), including 1–1.7% of people in the United States and roughly the same proportion in the European Union1.
- Shawn P. Iadonato is at Kineta, Inc., 307 Westlake Avenue North, Seattle, Washington 98109, USA.
Email: siadonato@kinetabio.com - Michael G. Katze is in the Department of Microbiology and the National Primate Center, University of Washington, Seattle, Washington 98195-8070, USA.
Email: honey@u.washington.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Interferon-alfa, interferon-λ and hepatitis CNature Genetics News and Views (01 Oct 2009)
RESEARCH
Antibody-Mediated Pure Red Cell Aplasia Due to Epoetin Alfa During Antiviral Therapy of Chronic Hepatitis CThe American Journal of Gastroenterology Correspondence
